Sachin Aggarwal

Senior Fellow, Munk School of Global Affairs & Public Policy
Headshot of Sachin Aggarwal

Biography

Main Bio

Sachin Aggarwal is a Canadian entrepreneur, lawyer, and executive with a distinguished career leading technology-driven organizations at the intersection of healthcare, data, and public policy. He is the Chief Executive Officer of Think Research Corporation, a Toronto-based healthcare technology company with 200 employees and operations across North America and Europe. Under his leadership, Think has grown into a global provider of digital clinical solutions, used by over 300,000 clinicians and licensed by more than 14,000 healthcare facilities worldwide.

Since assuming the CEO role, Sachin has transformed Think into a platform of complementary healthcare businesses, acquiring and scaling brands such as MDBriefCase, Rx Briefcase and Oncology Education (continuing medical education), PostCall (physician newsletter) and Pharmapod (medication safety and pharmacy compliance). Today, Think’s portfolio spans software-as-a-service, data infrastructure, healthcare services, and medical education—delivering evidence-based tools that support decision-making and improve patient outcomes.

In addition to his role at Think, Sachin is an active advisor and board member to multiple growth-stage companies, particularly in the technology and healthcare sectors, including Sciteline Inc, and LifeSpire Inc. Earlier in his career, he practiced law at Torys LLP, served as Deputy Chief of Staff to the Leader of the Official Opposition in Ottawa, and worked with several start-ups and public policy organizations. He currently sits on the board of the Council of Canadian Innovators.

Sachin was named one of Canada’s Top 40 Under 40 in 2017 and recognized by MaRS Discovery District’s Portraits of Innovation for his leadership in Canadian technology. He holds an MBA from the Rotman School of Management and a law degree from the University of Toronto, having been called to the Bar in Ontario and New York.

Updated July 2025